Medications

IPF drug fails in new trial

A new study has demonstrated no significant benefit of taking the drug bosentan for idiopathic pulmonary fibrosis (IPF).

Diseases, Conditions, Syndromes

Drug to tackle lung scarring shows promise

People with a lung scarring condition that leaves them fighting for breath could be helped by a new medication, research suggests.

Medical research

Chronic lung disease treatment hits speed bump

A promising avenue of research into chronic lung disease treatment has hit a speed bump, with a new study showing that 3D manufacturing mesenchymal stem cells (MSCs) may not be the panacea hoped for by researchers.

page 5 from 16